EP1487414A4 - Antibiotische zusammensetzung - Google Patents
Antibiotische zusammensetzungInfo
- Publication number
- EP1487414A4 EP1487414A4 EP03714005A EP03714005A EP1487414A4 EP 1487414 A4 EP1487414 A4 EP 1487414A4 EP 03714005 A EP03714005 A EP 03714005A EP 03714005 A EP03714005 A EP 03714005A EP 1487414 A4 EP1487414 A4 EP 1487414A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antibiotic composition
- antibiotic
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/092,811 US6623758B2 (en) | 2000-02-24 | 2002-03-07 | Cephalosporin-metronidazole antibiotic composition |
US10/093,214 US6638532B2 (en) | 2000-02-24 | 2002-03-07 | Tetracycline—doxycycline antibiotic composition |
US93321 | 2002-03-07 | ||
US92854 | 2002-03-07 | ||
US92811 | 2002-03-07 | ||
US92858 | 2002-03-07 | ||
US93214 | 2002-03-07 | ||
US10/092,854 US6627222B2 (en) | 2000-02-24 | 2002-03-07 | Amoxicillin-dicloxacillin antibiotic composition |
US10/093,321 US6610328B2 (en) | 2000-02-24 | 2002-03-07 | Amoxicillin-clarithromycin antibiotic composition |
US10/092,858 US6632453B2 (en) | 2000-02-24 | 2002-03-07 | Ciprofoxacin-metronidazole antibiotic composition |
PCT/US2003/007118 WO2003075852A2 (en) | 2002-03-07 | 2003-03-07 | Antibiotic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1487414A2 EP1487414A2 (de) | 2004-12-22 |
EP1487414A4 true EP1487414A4 (de) | 2007-12-12 |
Family
ID=27808882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03714005A Withdrawn EP1487414A4 (de) | 2002-03-07 | 2003-03-07 | Antibiotische zusammensetzung |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1487414A4 (de) |
JP (1) | JP2005526059A (de) |
CA (1) | CA2478121A1 (de) |
WO (1) | WO2003075852A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
AUPS167602A0 (en) * | 2002-04-12 | 2002-05-16 | F.H. Faulding & Co. Limited | An improved modified release preparation |
EP1771158A4 (de) * | 2004-07-02 | 2008-03-12 | Advancis Pharmaceutical Corp | Tablette für pulsierte abgabe |
EA200702221A1 (ru) * | 2005-04-12 | 2008-04-28 | Элан Фарма Интернэшнл Лимитед | Композиции с контролируемым высвобождением для лечения бактериальной инфекции, содержащие цефалоспорин |
CN101257892B (zh) | 2005-05-18 | 2013-01-02 | 达沃尔泰拉公司 | 吸附剂的结肠递送 |
US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
WO2009137672A1 (en) * | 2008-05-07 | 2009-11-12 | Salix Pharmaceuticals, Ltd. | Methods of treating bowel disease by administering a bowel cleanser and an antibiotic |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001062195A1 (en) * | 2000-02-24 | 2001-08-30 | Advancis Pharmaceutical Corporation | Antibiotic and antifungal compositions |
US20010046984A1 (en) * | 2000-02-24 | 2001-11-29 | Rudnic Edward M. | Antibiotic composition with inhibitor |
US20010048944A1 (en) * | 2000-02-24 | 2001-12-06 | Rudnic Edward M. | Antibiotic product, use and formulation thereof |
US20020013345A1 (en) * | 1998-10-09 | 2002-01-31 | Charles L. Berman | Treatment of diseases of the eye characterized by the formation of metalloproteinase |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS601128A (ja) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | 作用持続型セフアクロル製剤 |
JPS61210025A (ja) * | 1985-03-14 | 1986-09-18 | Teisan Seiyaku Kk | 安定化された抗生物質複合顆粒製剤 |
US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
JPS63162619A (ja) * | 1986-12-25 | 1988-07-06 | Teisan Seiyaku Kk | 遅溶性顆粒及びそれを用いた持続性複合顆粒 |
NL8800223A (nl) * | 1987-04-21 | 1988-11-16 | Philips Nv | Systeem voor het registreren van een informatiesignaal, alsmede een registratiedrager en registratieinrichting voor toepassing in het systeem. |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
AU7966694A (en) * | 1993-07-21 | 1996-05-02 | University Of Kentucky Research Foundation, The | A multicompartment hard capsule with control release properties |
DE19718012C1 (de) * | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
AUPP437698A0 (en) * | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
-
2003
- 2003-03-07 EP EP03714005A patent/EP1487414A4/de not_active Withdrawn
- 2003-03-07 WO PCT/US2003/007118 patent/WO2003075852A2/en active Application Filing
- 2003-03-07 JP JP2003574128A patent/JP2005526059A/ja active Pending
- 2003-03-07 CA CA002478121A patent/CA2478121A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020013345A1 (en) * | 1998-10-09 | 2002-01-31 | Charles L. Berman | Treatment of diseases of the eye characterized by the formation of metalloproteinase |
WO2001062195A1 (en) * | 2000-02-24 | 2001-08-30 | Advancis Pharmaceutical Corporation | Antibiotic and antifungal compositions |
US20010046984A1 (en) * | 2000-02-24 | 2001-11-29 | Rudnic Edward M. | Antibiotic composition with inhibitor |
US20010048944A1 (en) * | 2000-02-24 | 2001-12-06 | Rudnic Edward M. | Antibiotic product, use and formulation thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2003218024A1 (en) | 2003-09-22 |
WO2003075852A3 (en) | 2004-07-15 |
CA2478121A1 (en) | 2003-09-18 |
JP2005526059A (ja) | 2005-09-02 |
AU2003218024B2 (en) | 2008-09-11 |
WO2003075852A2 (en) | 2003-09-18 |
EP1487414A2 (de) | 2004-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0220467D0 (en) | Composition | |
GB0213638D0 (en) | Composition | |
IL163749A0 (en) | Novel florfenicol-type antibiotics | |
GB0305941D0 (en) | Composition | |
AU2003285288A1 (en) | Composition | |
EP1482957A4 (de) | Antibiotische konjugate | |
GB0318894D0 (en) | Composition | |
GB0203421D0 (en) | Composition | |
AU2003235708A1 (en) | Polytartrate composition | |
GB0227244D0 (en) | Composition | |
GB0208608D0 (en) | Composition | |
GB0203296D0 (en) | Novel composition | |
GB0203280D0 (en) | Anti-glycolytic composition | |
EP1487414A4 (de) | Antibiotische zusammensetzung | |
GB0211924D0 (en) | Composition | |
GB0218241D0 (en) | Composition | |
GB0318152D0 (en) | Composition | |
HK1082517A1 (en) | Oil-barrier composition | |
EP1495751A4 (de) | Haarfärbezusammensetzung | |
GB0315629D0 (en) | New uses for antibiotic | |
GB0229286D0 (en) | Composition | |
GB0205786D0 (en) | Novel Composition | |
GB0213767D0 (en) | Composition | |
GB0203616D0 (en) | Composition | |
GB0208301D0 (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040930 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WASSINK, SANDRA, E. Inventor name: TREACY, JR., DONALD, J. Inventor name: ISBISTER, JAMES, D. Inventor name: RUDNIC, EDWARD, M. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ADVANCIS PHARMACEUTICAL CORPORATION |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20071114 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MIDDLEBROOK PHARMACEUTICALS, INC. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MIDDLEBROOK PHARMACEUTICALS, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091001 |